Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma
Authors
Keywords
CXCR4, FAK, DOX, Resistance, Invasion, Non-small cell lung carcinoma
Journal
CELLULAR ONCOLOGY
Volume 40, Issue 1, Pages 47-62
Publisher
Springer Nature
Online
2016-11-07
DOI
10.1007/s13402-016-0304-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers
- (2016) Yu-Lun Chen et al. CELLULAR ONCOLOGY
- Selective targeting of FAK–Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells
- (2015) Amrita Datta et al. CANCER LETTERS
- RRM1 expression is associated with the outcome of gemcitabine-based treatment of non-small cell lung cancer patients–a short report
- (2015) Chuan Zeng et al. CELLULAR ONCOLOGY
- Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells
- (2015) Zeynep Birsu Cincin et al. CELLULAR ONCOLOGY
- MiR-138 and MiR-135 Directly Target Focal Adhesion Kinase, Inhibit Cell Invasion, and Increase Sensitivity to Chemotherapy in Cancer Cells
- (2014) Vita Golubovskaya et al. Anti-Cancer Agents in Medicinal Chemistry
- CXCL12/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562/ADM cells
- (2014) Yu Wang et al. BIOCHEMICAL PHARMACOLOGY
- Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles
- (2014) Chuda Chittasupho et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin
- (2014) Ling Mei et al. JOURNAL OF CONTROLLED RELEASE
- Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
- (2014) Bernardo Tavora et al. NATURE
- Effect of CXCL12/CXCR4 on increasing the metastatic potential of non-small cell lung cancer in vitro is inhibited through the downregulation of CXCR4 chemokine receptor expression
- (2014) SONGPING XIE et al. Oncology Letters
- The Role of Focal Adhesion Kinase in Lung Cancer
- (2013) Grace K. Dy Anti-Cancer Agents in Medicinal Chemistry
- IGFBP2/FAK Pathway Is Causally Associated with Dasatinib Resistance in Non-Small Cell Lung Cancer Cells
- (2013) H. Lu et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma
- (2013) Jerry E. Stewart et al. MOLECULAR CARCINOGENESIS
- Overexpression of focal adhesion kinase correlates with increased lymph node metastasis and poor prognosis in non-small-cell lung cancer
- (2012) Hong-Fei Ji et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Melatonin suppresses doxorubicin-induced premature senescence of A549 lung cancer cells by ameliorating mitochondrial dysfunction
- (2012) Naree Song et al. JOURNAL OF PINEAL RESEARCH
- Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells
- (2012) M-J Jung et al. ONCOGENE
- Potential of CXCR4 antagonists for the treatment of metastatic lung cancer
- (2011) Jan A Burger et al. Expert Review of Anticancer Therapy
- Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R)
- (2010) Tijana Andjelkovic et al. CANCER BIOLOGY & THERAPY
- Autocrine Induction of Invasive and Metastatic Phenotypes by the MIF-CXCR4 Axis in Drug-Resistant Human Colon Cancer Cells
- (2010) Anne-Frédérique Dessein et al. CANCER RESEARCH
- Coalterations of p53 and PTEN tumor suppressor genes in non–small cell lung carcinoma patients
- (2010) Tijana Andjelkovic et al. Translational Research
- CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
- (2009) A. K. Azab et al. BLOOD
- Targeted therapies in the treatment of advanced/metastatic NSCLC
- (2009) A.G. Pallis et al. EUROPEAN JOURNAL OF CANCER
- Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling
- (2009) Yuliya Pylayeva et al. JOURNAL OF CLINICAL INVESTIGATION
- Small Molecule Chloropyramine Hydrochloride (C4) Targets the Binding Site of Focal Adhesion Kinase and Vascular Endothelial Growth Factor Receptor 3 and Suppresses Breast Cancer Growth in Vivo
- (2009) Elena V. Kurenova et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B
- (2009) Bor-Sheng Ko et al. LIFE SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now